CART/CTL/DCvac cell therapy (Shenzhen Geno-Immune Medical Institute)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameCART/CTL/DCvac cell therapy (Shenzhen Geno-Immune Medical Institute)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulantsT lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Geno-Immune Medical Institute
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Geno-Immune Medical Institute
Inactive CompaniesN/A
Active IndicationsPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A